NCT02586129View on ClinicalTrials.gov

Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

November 4, 2015

Primary Completion Date

July 7, 2017

Study Completion Date

July 7, 2017

Conditions
DyslipidemiaType II Diabetes
Interventions
DRUG

YH14755

20/1500mg, QD

DRUG

Metformin

1500mg, QD

DRUG

Rosuvastatin

20mg, QD

Trial Locations (1)

463-707

Seoul National Universitiy Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02586129 - Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes | Biotech Hunter | Biotech Hunter